The Miami Entrepreneur

Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox

Read Time:6 Second

The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post We’re in our 60s and plan to claim Social Security at 70. Does delaying for maximum benefits really make sense? 
Next post Bond yields steady ahead of PCE inflation report